Literature DB >> 14985075

Hypoxia regulates the adenosine transporter, mENT1, in the murine cardiomyocyte cell line, HL-1.

Naz Chaudary1, Zlatina Naydenova, Irina Shuralyova, Imogen R Coe.   

Abstract

OBJECTIVE: Adenosine is an important paracrine hormone in the cardiovascular system. Adenosine flux across cardiomyocyte membranes occurs mainly via equilibrative nucleoside transporters (ENTs). The role of the ENTs in adenosine physiology is poorly understood, particularly in response to metabolic stress such as hypoxia. Therefore, we investigated the effects of chronic hypoxia on ENT1, the predominant ENT isoform in cardiomyocytes.
METHODS: HL-1 cells (immortalized murine cardiomyocytes) were exposed to hypoxia (2% O2) for 0-20 h. Cell viability, lactate dehydrogenase (LDH) release, glucose uptake, GLUT1 and GLUT4 protein, adenosine uptake, PKC activity, translocation profiles of PKCdelta and, nitrobenzylthioinosine (NBTI) binding and mENT1 mRNA levels were measured. The role of PKC in regulating mENT1 was further investigated using phorbol ester (100 nM, 18 h) and a dominant negative PKC construct, pSVK3PKC1-401.
RESULTS: HL-1 cells have typical cardiomyocyte responses to hypoxia based on cell viability, LDH release, glucose uptake and GLUT protein levels. Hypoxia (8-20 h) down-regulates mENT1-dependent adenosine uptake, NBTI-binding and PKC but not PKCdelta in HL-1 cells. Abrogation of PKC activity using chronic phorbol ester or a dominant negative PKC mimicked the effect of hypoxia on adenosine uptake suggesting that PKC is involved in regulation of mENT1. Hypoxia (4 h) decreases mENT1 mRNA, which returns to basal levels by 20 h.
CONCLUSIONS: Chronic hypoxia down-regulates mENT1 activity possibly via PKC. Hypoxia and PKC also regulate mENT1 RNA levels. Cardiomyocytes may regulate mENT1 (via PKC) to modulate release and/or uptake of adenosine. However, the relationship between mENT1 mRNA levels, protein levels and functional transport is complex.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14985075     DOI: 10.1016/j.cardiores.2003.11.031

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  15 in total

1.  Adaptive responses to purine starvation in Leishmania donovani.

Authors:  Nicola S Carter; Phillip A Yates; Sarah K Gessford; Sean R Galagan; Scott M Landfear; Buddy Ullman
Journal:  Mol Microbiol       Date:  2010-10       Impact factor: 3.501

Review 2.  Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery.

Authors:  Sean P Colgan; Holger K Eltzschig
Journal:  Annu Rev Physiol       Date:  2011-11-19       Impact factor: 19.318

3.  Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle.

Authors:  I Chopra; H F Li; H Wang; K A Webster
Journal:  Diabetologia       Date:  2011-12-30       Impact factor: 10.122

Review 4.  Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation.

Authors:  Holger K Eltzschig; Jesus Rivera-Nieves; Sean P Colgan
Journal:  Expert Opin Ther Targets       Date:  2009-11       Impact factor: 6.902

5.  Hypoxia-inducible factor-1α (HIF-1α) protein diminishes sodium glucose transport 1 (SGLT1) and SGLT2 protein expression in renal epithelial tubular cells (LLC-PK1) under hypoxia.

Authors:  Juan R Zapata-Morales; Othir G Galicia-Cruz; Martha Franco; Flavio Martinez Y Morales
Journal:  J Biol Chem       Date:  2013-11-06       Impact factor: 5.157

6.  Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury.

Authors:  Tobias Eckle; Kelly Hughes; Heidi Ehrentraut; Kelley S Brodsky; Peter Rosenberger; Doo-Sup Choi; Katya Ravid; Tingting Weng; Yang Xia; Michael R Blackburn; Holger K Eltzschig
Journal:  FASEB J       Date:  2013-04-19       Impact factor: 5.191

7.  Hypoxia alters ocular drug transporter expression and activity in rat and calf models: implications for drug delivery.

Authors:  Rajendra S Kadam; Preveen Ramamoorthy; Daniel J LaFlamme; Timothy A McKinsey; Uday B Kompella
Journal:  Mol Pharm       Date:  2013-05-22       Impact factor: 4.939

Review 8.  Genetic factors influencing cytarabine therapy.

Authors:  Jatinder K Lamba
Journal:  Pharmacogenomics       Date:  2009-10       Impact factor: 2.533

Review 9.  Ethanol for cardiac ischemia: the role of protein kinase c.

Authors:  Eric N Churchill; Marie-Helene Disatnik; Grant R Budas; Daria Mochly-Rosen
Journal:  Ther Adv Cardiovasc Dis       Date:  2008-12

10.  The adenosine transporter, ENT1, in cardiomyocytes is sensitive to inhibition by ethanol in a kinase-dependent manner: implications for ethanol-dependent cardioprotection and nucleoside analog drug cytotoxicity.

Authors:  Azza Ramadan; Zlatina Naydenova; Katarina Stevanovic; Jennifer B Rose; Imogen R Coe
Journal:  Purinergic Signal       Date:  2013-10-27       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.